We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,842

New Study Reevaluates Effect of Fat Intake on Cholesterol and Heart Disease Risk
  • Shook Hardy & Bacon LLP
  • USA
  • April 15 2016

A study reevaluating "the traditional diet-heart hypothesis" concludes that replacing dietary saturated fat with vegetable oils lowers serum


Salt Institute Disputes Sodium Recommendations in Federal Dietary Guidelines
  • Shook Hardy & Bacon LLP
  • USA
  • April 15 2016

The Salt Institute has penned an April 11, 2016, letter asking the U.S. Department of Agriculture (USDA) and Department of Health and Human Services


Hospital walks back study linking aspartame to leukemia
  • Shook Hardy & Bacon LLP
  • USA
  • October 26 2012

Brigham and Women’s Hospital (BWM) has reportedly walked back a recent study claiming to link aspartame with an increased risk of leukemia, non- Hodgkin’s lymphoma (NHL) and other blood-related cancers


Pelman v. McDonald’s Corp.: no class certification for obese teens
  • Shook Hardy & Bacon LLP
  • USA
  • October 29 2010

A judge from the U.S. Court of International Trade, sitting by designation in a New York federal district court, has determined that the obesity-related claims filed in 2002 against McDonald’s Corp. cannot be pursued as a class action


Energy drink makers target new demographic
  • Shook Hardy & Bacon LLP
  • USA
  • August 23 2013

Although the typical energy drink user is reportedly young and male, a recent news source indicates that a new demographic is emerging as a top


Guardian Author Takes on Nutritional Establishment in “The Sugar Conspiracy”
  • Shook Hardy & Bacon LLP
  • USA
  • April 8 2016

In this April 7, 2016, article about changing dietary recommendations and rising obesity rates, Ian Leslie resurrects the forgotten work of John


FDA refuses to re-classify tooth-whitening products as drugs
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2014

The U.S. Food and Drug Administration (FDA) has denied a Citizen Petition asking the agency to re-categorize tooth-whitening products as drugs


Lab Trade Association presses FDA on plan to regulate laboratory developed tests
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

The American Clinical Laboratory Association (ACLA) has submitted a citizen petition to the Food and Drug Administration (FDA), asking the agency to


Landmark Texas Supreme Court decision: learned intermediary doctrine applies in prescription drug cases, no DTC exception
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2012

Addressing the issue squarely for the first time, the Texas Supreme Court has unanimously adopted the learned intermediary doctrine in the prescription drug context thereby confirming that manufacturers are only obligated to warn doctors of the risks of prescription medicines


FDA's regulation of trans fats
  • Shook Hardy & Bacon LLP
  • USA
  • January 24 2014

More than 100 years after the advent of artificial trans fats, the U.S. Food and Drug Administration (FDA) has taken the first step toward banning